Aspa-flox 基因敲除小鼠

1. Wang, Jiang-Hui, Gessler, Dominic J, Zhan, Wei, Gallagher, Thomas L, Gao, Guangping. 2024. Adeno-associated virus as a delivery vector for gene therapy of human diseases. In Signal transduction and targeted therapy, 9, 78. doi:10.1038/s41392-024-01780-w. https://pubmed.ncbi.nlm.nih.gov/38565561/

2. Chao, Jianfei, Feng, Lizhao, Ye, Peng, Matalon, Reuben, Shi, Yanhong. 2022. Therapeutic development for Canavan disease using patient iPSCs introduced with the wild-type ASPA gene. In iScience, 25, 104391. doi:10.1016/j.isci.2022.104391. https://pubmed.ncbi.nlm.nih.gov/35637731/

3. Xie, Qing, Chen, Xiupeng, Ma, Hong, Gao, Guangping, Xie, Jun. 2024. Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor. In EMBO molecular medicine, 16, 945-965. doi:10.1038/s44321-024-00037-x. https://pubmed.ncbi.nlm.nih.gov/38413838/

4. Wang, Dan, Zhang, Feng, Gao, Guangping. . CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors. In Cell, 181, 136-150. doi:10.1016/j.cell.2020.03.023. https://pubmed.ncbi.nlm.nih.gov/32243786/